Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Robert Pesek

Concepts (134)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Enteritis
11
2024
19
5.800
Why?
Gastritis
11
2024
32
5.710
Why?
Eosinophilia
10
2024
37
4.810
Why?
Eosinophilic Esophagitis
11
2024
34
4.080
Why?
Eosinophils
5
2024
39
2.210
Why?
Desensitization, Immunologic
6
2022
107
1.920
Why?
Colitis
2
2019
50
1.310
Why?
Allergens
4
2024
139
0.910
Why?
Endoscopy, Gastrointestinal
3
2022
73
0.770
Why?
Hypersensitivity
2
2023
77
0.760
Why?
Molecular Targeted Therapy
2
2019
119
0.750
Why?
Anaphylaxis
2
2018
71
0.720
Why?
Gastroenteritis
1
2019
17
0.670
Why?
Gastrointestinal Agents
1
2019
34
0.660
Why?
Esophagus
3
2024
84
0.660
Why?
Acetazolamide
1
2018
19
0.630
Why?
Pseudotumor Cerebri
1
2018
24
0.620
Why?
Drug Hypersensitivity
1
2018
36
0.610
Why?
Anti-Inflammatory Agents
1
2019
161
0.610
Why?
Intestinal Mucosa
1
2019
225
0.600
Why?
Drug Design
1
2018
120
0.590
Why?
Anticonvulsants
1
2018
121
0.580
Why?
Immunoglobulin E
2
2016
92
0.560
Why?
Practice Guidelines as Topic
1
2019
449
0.560
Why?
Food Hypersensitivity
2
2017
100
0.530
Why?
Immune Tolerance
4
2022
96
0.520
Why?
Schnitzler Syndrome
1
2014
4
0.490
Why?
Humans
29
2024
49974
0.490
Why?
Child
15
2024
6847
0.480
Why?
Interleukin-1beta
1
2014
75
0.460
Why?
Peanut Hypersensitivity
3
2022
88
0.450
Why?
Mycobacterium fortuitum
1
2013
6
0.440
Why?
Macrolides
1
2013
16
0.440
Why?
Clarithromycin
1
2013
38
0.430
Why?
Milk Hypersensitivity
2
2024
19
0.430
Why?
Child, Preschool
9
2024
3871
0.420
Why?
Antibodies, Monoclonal
1
2014
459
0.360
Why?
Urticaria
3
2015
18
0.360
Why?
Infant
8
2024
3567
0.350
Why?
Proton Pump Inhibitors
3
2024
84
0.350
Why?
Asthma
2
2023
281
0.340
Why?
Clinical Trials as Topic
2
2022
461
0.320
Why?
Adolescent
6
2019
6356
0.320
Why?
Antibodies, Monoclonal, Humanized
2
2024
225
0.320
Why?
Female
15
2024
26472
0.310
Why?
Treatment Outcome
6
2024
5141
0.300
Why?
Synbiotics
2
2024
3
0.280
Why?
Administration, Oral
3
2022
426
0.270
Why?
Male
13
2024
25241
0.250
Why?
Allergy and Immunology
1
2024
14
0.240
Why?
Congresses as Topic
1
2024
44
0.240
Why?
Infant Formula
2
2024
145
0.220
Why?
United States
3
2024
4860
0.220
Why?
Amino Acids
2
2024
360
0.210
Why?
Food Supply
1
2023
91
0.210
Why?
Outpatients
1
2023
113
0.210
Why?
Middle Aged
6
2021
12069
0.200
Why?
Adult
7
2023
13236
0.190
Why?
Young Adult
3
2019
3958
0.190
Why?
Injections, Subcutaneous
2
2024
54
0.180
Why?
Follow-Up Studies
3
2024
2182
0.180
Why?
Biological Therapy
1
2019
16
0.170
Why?
Leukocyte Count
1
2019
70
0.170
Why?
Standard of Care
1
2019
16
0.170
Why?
Ulcer
1
2019
22
0.170
Why?
Erythema
1
2019
38
0.170
Why?
Disease Susceptibility
1
2019
89
0.170
Why?
Double-Blind Method
4
2024
681
0.170
Why?
Colon
1
2019
98
0.170
Why?
Intestine, Small
1
2019
109
0.160
Why?
Stomach
1
2019
80
0.160
Why?
Retrospective Studies
3
2019
6108
0.160
Why?
Epinephrine
2
2016
96
0.160
Why?
Hypersensitivity, Immediate
1
2018
11
0.160
Why?
Wiskott-Aldrich Syndrome Protein
1
2018
2
0.160
Why?
Wiskott-Aldrich Syndrome
1
2018
3
0.160
Why?
Forecasting
1
2019
150
0.160
Why?
Disease Management
1
2019
174
0.160
Why?
Combined Modality Therapy
1
2019
637
0.150
Why?
Biopsy
1
2019
584
0.150
Why?
Gastroesophageal Reflux
1
2017
49
0.150
Why?
Particulate Matter
1
2017
52
0.150
Why?
Inflammation
1
2021
604
0.150
Why?
Immunization
1
2017
67
0.150
Why?
Comorbidity
1
2019
615
0.140
Why?
Seasons
1
2017
81
0.140
Why?
Consensus
3
2022
148
0.140
Why?
Deglutition Disorders
1
2017
77
0.140
Why?
Sympathomimetics
1
2016
21
0.140
Why?
Glucocorticoids
1
2018
219
0.140
Why?
Incidence
1
2019
1003
0.130
Why?
Disaccharides
1
2015
11
0.130
Why?
Meat
1
2015
55
0.130
Why?
Environmental Exposure
1
2017
199
0.130
Why?
Cohort Studies
1
2019
1422
0.130
Why?
Flow Cytometry
1
2018
476
0.130
Why?
Prospective Studies
2
2021
2364
0.130
Why?
Longitudinal Studies
1
2017
688
0.120
Why?
Celiac Disease
1
2014
9
0.120
Why?
Hypothyroidism
1
2014
54
0.110
Why?
Animals
3
2024
13187
0.110
Why?
Fever
1
2014
114
0.110
Why?
Amikacin
1
2013
19
0.110
Why?
Azithromycin
1
2013
25
0.110
Why?
Skin Tests
1
2013
58
0.110
Why?
Arkansas
1
2017
1977
0.100
Why?
Diagnosis, Differential
1
2014
1037
0.090
Why?
Aged
2
2021
9310
0.090
Why?
Severity of Illness Index
2
2022
945
0.080
Why?
Diabetes Mellitus, Type 2
1
2014
477
0.080
Why?
Infant, Newborn
3
2021
2772
0.070
Why?
Interleukin-13
1
2024
15
0.060
Why?
Interleukin-4
1
2024
43
0.060
Why?
Remission Induction
1
2024
207
0.060
Why?
Cattle
1
2024
210
0.060
Why?
Milk
1
2024
85
0.060
Why?
Spirometry
1
2023
29
0.060
Why?
Nutritional Status
1
2023
141
0.050
Why?
International Cooperation
1
2021
44
0.050
Why?
Electronic Health Records
1
2023
209
0.050
Why?
Health Promotion
1
2023
271
0.050
Why?
Dose-Response Relationship, Drug
1
2024
1376
0.050
Why?
Primary Health Care
1
2023
358
0.040
Why?
Constipation
1
2017
35
0.040
Why?
Vomiting
1
2017
75
0.040
Why?
Diarrhea
1
2017
92
0.040
Why?
Histamine Antagonists
1
2016
19
0.040
Why?
Administration, Cutaneous
1
2016
51
0.030
Why?
Sensitivity and Specificity
1
2018
861
0.030
Why?
Quality of Life
1
2021
836
0.030
Why?
Mass Screening
1
2018
353
0.030
Why?
Patient Compliance
1
2016
230
0.030
Why?
Swine
1
2015
393
0.030
Why?
Randomized Controlled Trials as Topic
1
2016
549
0.030
Why?
Pesek's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description